Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -7982.00x is 160% below its 1-year average of -3075.22x, near the low end of its 1-year range (-7982.00x–-451.00x).
As of the fiscal period ended Wednesday, June 30, 2021. 166.51% below its 12-month average of -2995.00x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2021 (2021-06-30): -7982.00x.
INTEREST COVERAGE RATIO
-7982.00x
INTEREST COVERAGE RATIO AVG TTM
-2995.00x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-166.51%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.21x
median of 340 covered companies
CURRENT VS SECTOR MEDIAN
-189496.20%
vs the sector median at left
Caribou Biosciences, Inc.
Market Cap
$118.52M
Interest Coverage Ratio
-7982.00x
TTM Avg
-2995.00x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$119.09M
Interest Coverage Ratio
-50.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$117.03M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$116.84M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$120.80M
Interest Coverage Ratio
-280.53x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$115.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$114.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$122.26M
Interest Coverage Ratio
-41.14x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | $118.52M | -7982.00x | -2995.00x | N/A | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $119.09M | -50.85x | N/A | N/A | N/A |
| Genelux Corporation (GNLX)vs › | $117.03M | N/A | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $116.84M | N/A | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.80M | -280.53x | N/A | N/A | N/A |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $115.66M | N/A | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $114.76M | N/A | N/A | N/A | N/A |
| Coya Therapeutics, Inc. (COYA)vs › | $114.71M | N/A | N/A | N/A | N/A |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | -41.14x | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.58M | N/A | N/A | N/A | N/A |
Interest Coverage
-7982.0x
Debt/Equity
0.27
Current Ratio
6.49
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-06-30 | -7982.00x |
| 2021-03-31 | -2635.00x |
| 2020-12-31 | -2535.50x |
| 2020-09-30 | -1371.50x |
| 2020-06-30 | -451.00x |
| 2020-03-31 | -3476.33x |
